| West Point Optical Group | |
|
6650 S Westnedge Ave, Suite 232, Portage, MI 49024-3597 | |
| (269) 237-2881 | |
| Not Available |
| Full Name | West Point Optical Group |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 6650 S Westnedge Ave, Portage, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134599756 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| West Point Optical Group 3775 Easton Way, Columbus, OH 43219-6149 Ph: () - | West Point Optical Group 6650 S Westnedge Ave, Suite 232, Portage, MI 49024-3597 Ph: (269) 237-2881 |
News Archive
Racial minorities comprise around a quarter of Utah's population but represent a third of COVID-19 cases in the state. A similar story has played out across the country. Why have racial minorities been unequally affected by the COVID-19 pandemic?
Cerulean Pharma Inc., a leader in developing dynamically tumor-targeted nanopharmaceuticals, today announced that the first patient has been dosed in a Phase 1b/2a study of its lead product candidate, CRLX101, in combination with Avastin, in metastatic renal cell carcinoma (mRCC) patients. The company also announced the completion of enrollment of its randomized Phase 2 study in advanced non-small cell lung cancer.
Salix Pharmaceuticals, Ltd. today reported that the Gastrointestinal Drugs Advisory Committee of the FDA has recommended by a vote of 14 to 4 in favor of the approval of XIFAXAN® (rifaximin) Tablets, 550 mg for the maintenance of remission of hepatic encephalopathy (HE).
Elsevier, the world's leading publisher of scientific, technical, and medical information products and services, today announced an exclusive partnership with The American Society of Radiologic Technologists (ASRT) to provide a complete series of computed tomography modules through Mosby's Imaging Suite for technologists' continuing education.
Hampering the transport of proteins within cells may underlie several adult-onset neurodegenerative diseases, such as Huntington's, ALS and Kennedy disease. Understanding how this cell transport is blocked in these diseases may offer targets for future therapy.
› Verified 8 days ago
Dr. Katie Lynne Sutter, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 6101 Newport Rd Ste A, Portage, MI 49002 Phone: 269-382-6500 Fax: 269-382-2286 | |
Mr. David C Mcclintic, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 6123 S Westnedge Ave, Portage, MI 49002 Phone: 269-327-7079 Fax: 269-327-7165 | |
Dr. Lynnette Raye Blostica, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3412 W Centre Ave, Portage, MI 49024 Phone: 269-329-5860 Fax: 269-329-5865 | |
David P Williams, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 410 E Centre Ave, Portage, MI 49002 Phone: 269-327-4454 Fax: 269-327-8717 | |
Dr. Steven S. Ellinger, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1612 E. Centre Ave., Portage, MI 49002 Phone: 269-329-1030 Fax: 269-329-0966 | |
Ferris R Standiford, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3412 W Centre Ave, Portage, MI 49024 Phone: 269-329-5870 Fax: 269-329-5865 |